DEVELOPMENT OF VORINOSTAT LOADED HYALURONIC ACID-COATED SOLID LIPID NANOPARTICLES FOR TARGETED DELIVERY TO CD44 OVEREXPRESSING CANCER CELLS
- At: 2015 FIP Congress in Düsseldorf (Germany)
- Type: Poster
- By: TAK, Jin Wook (Yeungnam University, Daegu, South-Korea)
- Co-author(s): Chul, Soon Yong (, South-Korea)
Vorinostat (VRS) is a histone deacetylase inhibitor that has been approved for the treatment of cancer which can effectively induce cell cycle arrest, cell differentiation, and apoptosis. However, the clinical efficacy of VRS has been limited by its poor aqueous solubility and low permeability.
HA-coated VRS-loaded SLNs (HA-VRS-SLNs) through.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.